升白快煎剂治疗白细胞减少症临床疗效观察

研究开发经口服途径作用快，药效高的升白细胞新药。方法将９０例血液恶性疾病化疗后白细胞减少患者分为３组，即升白快煎观察组，升白安片对照 和空白组进行疗效观察和对比。

A Clinical Observation on the Leukopenia Treated with Shengbaikuai Decoction

Objective: To study the effective orally taken medicine in treating the leukopenia. Methods: ninety cases of leukopenia induced by chemotherapy were divided into 3 groups. They were test group treated with Shengbaikuai Decoction (SBK), control group and blank group. Their efficacies were compared with each other, 25 cases with nonchemotherapy were also observed. Results: WBC count and absolute neutrophil count (ANC) in test group were higher than those of other groups immediately after treatment and 2 weeks later (P<0 01). The marked effective rate and total effective rate of test group after 2 weeks were 60.0% and 80.0% (P<0 001) respectively, which were significantly higher than those of other groups. WBC and ANC count after treatment and 3 weeks later were higher than those before treatment in nonchemotherapy group (P<0 001). The marked effective rate and total effective rate 3 weeks later were 64.0% and 80.0% respectively. Conclusions: SBK could increase WBC count rapidly and definitely without apparent side effect.